Partnering News

03.12.2018

BIOGEN TO ACQUIRE FROM PFIZER FIRST-IN-CLASS PHASE 2b READY ASSET FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA

03.09.2018

AM‐Pharma announces Phase II study results of recAP in sepsis‐associated Acute Kidney Injury

03.02.2018

Neofluidics Announces Collaboration with Pfizer Inc.

02.28.2018

Inserm announces research agreement with Pfizer Inc. to study rare neuromuscular disease

01.22.2018

MINDIMMUNE THERAPEUTICS TO CONDUCT RESEARCH ON SPECIALIZED IMMUNE CELLS WITH PFIZER INC.

01.17.2018

Circle Pharma announces publication in Journal of Medicinal Chemistry of results from collaboration with Pfizer Inc.

01.09.2018

Adapsyn Bioscience Completes Financing to Advance its Small Molecule Natural Products Platform and Pipeline; Announces Research Collaboration with Pfizer Inc.

01.08.2018

Imcyse announces a research collaboration with Pfizer Inc. in rheumatoid arthritis (RA)

01.08.2018

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available ‘Big Data’ Human Sequencing Resource with UK Biobank

01.08.2018

Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel and Innovative Seed-Stage Life Science Funding Model and a Natural Extension of Alexandria LaunchLabs

01.05.2018

Distributed Bio Announces SuperHuman Platform License Agreement with Pfizer Inc.

01.05.2018

Distributed Bio Announces SuperHuman Platform License Agreement with Pfizer Inc.